Press releases
- Politan Files Preliminary Proxy Statement
- Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM™ Wearable Continuous Vital Signs Monitors
- Masimo Announces Nomination of Independent Candidate to the Board of Directors
- Masimo to Present in Jefferies Global Healthcare Conference
- Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
- Masimo Receives Sustainability Seal of Approval from Practice Greenhealth
- Masimo and Denon Introduce White PerL™ and PerL Pro™ Earbuds, Redefining Style and Customization in Personalized Audio
- Masimo to Present in BofA Securities Health Care Conference
- Masimo Reports First Quarter 2024 Financial Results
- Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
More ▼
Key statistics
On Monday, Masimo Corp (3M4:FRA) closed at 116.40, -25.14% below its 52-week high of 155.50, set on Jun 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 116.40 |
---|---|
High | 116.40 |
Low | 116.40 |
Bid | 117.25 |
Offer | 118.05 |
Previous close | 115.60 |
Average volume | 3.57 |
---|---|
Shares outstanding | 53.09m |
Free float | 49.03m |
P/E (TTM) | 85.04 |
Market cap | 6.61bn USD |
EPS (TTM) | 1.46 USD |
Data delayed at least 15 minutes, as of Jun 03 2024 08:38 BST.
More ▼